{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:55:06Z","timestamp":1781592906264,"version":"3.54.5"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":508,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jvs.2022.04.047","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T01:59:04Z","timestamp":1655085544000},"page":"1053-1059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["P2Y12 inhibitor monotherapy is associated with superior outcomes\u00a0as compared with aspirin monotherapy in chronic limb-threatening ischemia"],"prefix":"10.1016","volume":"76","author":[{"given":"Sikandar Z.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica S.","family":"O\u2019Brien-Irr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Fakhoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Montross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariel","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan H.","family":"Dosluoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej L.","family":"Dryjski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6 Suppl","key":"10.1016\/j.jvs.2022.04.047_bib1","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global Vascular Guidelines on the management of chronic limb threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.04.047_bib2","first-page":"e71","article-title":"AHA\/ACC guidelines on the management of patients with lower extremity peripheral arterial disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2022.04.047_bib3","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1161\/CIRCULATIONAHA.117.024469","article-title":"A\u00a0structured review of antithrombotic therapy in peripheral arterial disease with a focus on revascularization a TASC (InterSociety Consensus for the Management of Peripheral Arterial Disease) Initiative","volume":"135","author":"Hess","year":"2017","journal-title":"Circulation"},{"issue":"3 Suppl","key":"10.1016\/j.jvs.2022.04.047_bib4","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J\u00a0Vasc Sur"},{"key":"10.1016\/j.jvs.2022.04.047_bib5","doi-asserted-by":"crossref","first-page":"e669S","DOI":"10.1378\/chest.11-2307","article-title":"Antithrombotic therapy in peripheral arterial disease: anti- thrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Alonso-Coello","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jvs.2022.04.047_bib6","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehr211","volume":"32","author":"Tendera","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2022.04.047_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s40119-019-00153-7","article-title":"A\u00a0review of antithrombotic treatment in critical limb ischemia after endovascular intervention","volume":"8","author":"Gupta","year":"2019","journal-title":"Cardiol Ther"},{"key":"10.1016\/j.jvs.2022.04.047_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.carrev.2016.07.006","article-title":"Long term use of dual antiplatelet therapy for secondary prevention of atherosclerotic events: meta-analysis of randomized controlled trials","volume":"18","author":"Fanari","year":"2017","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jvs.2022.04.047_bib9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1583\/13-4275MR.1","article-title":"Twelve-month results of a randomized trial comparing mono with dual antiplatelet therapy in endovascularly treated patients with peripheral arterial disease","volume":"20","author":"Strobl","year":"2013","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2022.04.047_bib10","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.jcin.2019.08.006","article-title":"Optimal strategy for antiplatelet therapy after endovascular revascularization for lower extremity peripheral artery disease","volume":"12","author":"Cho","year":"2019","journal-title":"JACC Cardiovasc Intervent"},{"key":"10.1016\/j.jvs.2022.04.047_bib11","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.jvs.2020.02.041","article-title":"Improved survival with angiotension-converting enzyme inhibitors and angiotension receptor blockers in chronic limb threatening ischemia","volume":"72","author":"Khan","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.04.047_bib12","doi-asserted-by":"crossref","first-page":"e0135692","DOI":"10.1371\/journal.pone.0135692","article-title":"Comparative efficacy and safety of different antiplatelet agents for prevention of major cardiovascular events and leg amputations in patients with peripheral arterial disease: a systematic review and network analysis","volume":"10","author":"Katsanos","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jvs.2022.04.047_bib13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2174\/1570161118666200820141131","article-title":"Efficacy and safety of antiplatelet therapies in symptomatic peripheral arterial disease: a systematic review and network meta-analysis","volume":"19","author":"De Carlo","year":"2021","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jvs.2022.04.047_bib14","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A\u00a0randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2022.04.047_bib15","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.jvs.2016.05.098","article-title":"Dual antiplatelet is associated with prolonged survival after lower extremity revascularization","volume":"64","author":"Soden","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.04.047_bib16","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2022.04.047_bib17","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521422016287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521422016287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:38:10Z","timestamp":1760042290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521422016287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0741521422016287"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2022.04.047","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P2Y12 inhibitor monotherapy is associated with superior outcomes\u00a0as compared with aspirin monotherapy in chronic limb-threatening ischemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2022.04.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}